Source: https://www.law.cornell.edu/cfr/text/21/522.2460
Timestamp: 2015-11-26 23:17:33
Document Index: 727366822

Matched Legal Cases: ['art 522', '§ 522', '§ 556', '§ 522', '§ 510', '§ 556', 'art 522']

21 CFR 522.2460 - Tildipirosin. | US Law | LII / Legal Information Institute
CFR › Title 21 › Chapter I › Subchapter E › Part 522 › Section 522.2460 21 CFR 522.2460 - Tildipirosin.
§ 522.2460
Each milliliter of solution contains:
180 milligrams (mg) tildipirosin.
See § 556.733 of this chapter.
Administer 4 mg/kg of bodyweight one time by subcutaneous injection in the neck.
For the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in beef and non-lactating dairy cattle; and for the control of respiratory disease in beef and non-lactating dairy cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, and H. somni.
Cattle intended for human consumption must not be slaughtered within 21 days from the last treatment. Do not use in female dairy cattle 20 months of age or older. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
§ 522.2460 Tildipirosin.
Specifications. Each milliliter of solution contains:
(1) 180 milligrams (mg) tildipirosin.
Sponsor. See No. 000061 in § 510.600(c) of this chapter.
Related tolerances. See § 556.733 of this chapter.
Cattle - (i)
Amount. Administer 4 mg/kg of bodyweight one time by subcutaneous injection in the neck.
Indications for use. For the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in beef and non-lactating dairy cattle; and for the control of respiratory disease in beef and non-lactating dairy cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, and H. somni.
Limitations. Cattle intended for human consumption must not be slaughtered within 21 days from the last treatment. Do not use in female dairy cattle 20 months of age or older. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Title 21 published on 2015-04-01The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 21 CFR Part 522 after this date.2015-10-13; vol. 80 # 197 - Tuesday, October 13, 201580 FR 61293 - New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of a New Animal Drug Application; Change of Sponsor; Change of Sponsor&apos;s Address